The prevalence of mitochondrial mutations associated with aminoglycoside-induced sensorineural hearing loss in an NICU population
โ Scribed by Megan Ealy; Katherine A. Lynch; Nicole C. Meyer; Richard J.H. Smith
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 80 KB
- Volume
- 121
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Several mitochondrial DNA variants increase risk for developing sensorineural hearing loss following exposure to aminoglycoside antibiotics, a particular concern in the premature infant population, as many of these babies spend time in neonatal intensive care units and are treated with aminoglycosides. To determine the relative prevalence of five mitochondrial DNA variants in the 12S rRNA gene, MTโRNR1, we genotyped 703 neonatal intensive care unit patients and 1,473 individuals from the general Iowa population. We found that the aggregate frequency of these variants (โผ1.8%) was comparable between populations. Although no hearing loss was detected by newborn hearing screens in the atโrisk patients, these neonatal intensive care unit graduates have an increased lifeโtime risk for developing aminoglycosideโinduced deafness.
๐ SIMILAR VOLUMES
Hereditary hearing loss (HHL) is one of the most common congenital disorders and is highly heterogeneous. Mutations in the connexin 26 (CX26) gene (GJB2) account for about 20% of all cases of childhood deafness, and approach 50% in documented recessive cases of non-syndromic hearing loss. In additio